FHH-Chr 14BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
9 |
|
0.24 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15439 |
381 |
FHH-Chr 14BN/Mcwi |
percent change in ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
141.18 |
% |
7.7 |
24.34 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13722 |
381 |
FHH-Chr 14BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
9 |
|
166.95 |
breaths/min |
11.41 |
34.22 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17153 |
381 |
FHH-Chr 14BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.2 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18013 |
381 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
37.25 |
ml/min |
2.39 |
7.56 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18704 |
381 |
FHH-Chr 14BN/Mcwi |
serum calcium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77 days-91 days |
8 |
|
9.24 |
mg/dl |
0.16 |
0.46 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36655 |
401 |
FHH-Chr 14BN/Mcwi |
time to onset of heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
6 |
|
965.13 |
s |
35.13 |
86.06 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49340 |
461 |
FHH-Chr 14BN/Mcwi |
heart contraction pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
6 |
|
25.83 |
mmHg |
6.05 |
14.81 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50038 |
461 |
FHH-Chr 14BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49 days-63 days |
6 |
|
8.09 |
% |
3.94 |
9.65 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49437 |
461 |
FHH-Chr 14BN/Mcwi |
mean corpuscular volume |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77 days-91 days |
8 |
|
58.31 |
fl |
0.44 |
1.24 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38776 |
401 |
FHH-Chr 14BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77 days-91 days |
8 |
|
0.49 |
x 1000 cells/ul |
0.1 |
0.28 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38882 |
401 |
FHH-Chr 14BN/Mcwi |
serum bicarbonate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77 days-91 days |
8 |
|
20.75 |
mmol/l |
0.96 |
2.71 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42103 |
401 |
FHH-Chr 14BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
17.5 |
pg |
0.13 |
0.36 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40200 |
401 |
FHH-Chr 14BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77 days-91 days |
8 |
|
0.24 |
x 1000 cells/ul |
0.03 |
0.09 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40296 |
401 |
FHH-Chr 14BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
body mass |
female |
77 days-91 days |
10 |
|
103.8 |
g |
4.0 |
12.6 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59093 |
526 |
FHH-Chr 14BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77 days-91 days |
8 |
|
4.06 |
mmol/l |
0.16 |
0.45 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43313 |
401 |
FHH-Chr 14BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77 days-91 days |
8 |
|
107.5 |
mmol/l |
0.76 |
2.14 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40008 |
401 |
FHH-Chr 14BN/Mcwi |
blood lymphocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77 days-91 days |
8 |
|
4.57 |
x 1000 cells/ul |
0.44 |
1.24 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41534 |
401 |
FHH-Chr 14BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77 days-91 days |
8 |
|
19.38 |
mg/dl |
1.59 |
4.5 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41754 |
401 |
FHH-Chr 14BN/Mcwi |
plasma anion gap |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77 days-91 days |
8 |
|
18.0 |
mmol/l |
1.27 |
3.59 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38292 |
401 |
FHH-Chr 14BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
1.0 |
g/mg |
0.16 |
0.49 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57311 |
522 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
23.94 |
ml/min |
1.82 |
5.76 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16178 |
381 |
FHH-Chr 14BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
5 |
|
17.5 |
ml/min/kg |
1.12 |
2.5 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57629 |
526 |
FHH-Chr 14BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
9 |
|
15.97 |
ml/min/kg |
0.99 |
2.96 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57639 |
526 |
FHH-Chr 14BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77 days-91 days |
10 |
|
146.8 |
g |
2.1 |
6.5 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58324 |
526 |
FHH-Chr 14BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77 days-91 days |
10 |
|
150.6 |
g |
10.0 |
31.5 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58340 |
526 |
FHH-Chr 14BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
-7.72 |
null |
0.06 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56098 |
522 |
FHH-Chr 14BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
8 |
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54651 |
522 |
FHH-Chr 14BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54899 |
522 |
FHH-Chr 14BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
female |
77 days-91 days |
5 |
|
0.02 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58520 |
526 |
FHH-Chr 14BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
22.05 |
ml/min/kg |
2.81 |
7.94 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58625 |
526 |
FHH-Chr 14BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.28 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17401 |
381 |
FHH-Chr 14BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
9 |
|
0.32 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17412 |
381 |
FHH-Chr 14BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
4 |
|
0.39 |
IU/g |
0.19 |
0.39 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47425 |
461 |
FHH-Chr 14BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
6 |
|
213.6 |
beats/min |
8.84 |
21.66 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48238 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
79.29 |
% |
19.42 |
51.37 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46097 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
92.92 |
% |
3.0 |
7.34 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48336 |
461 |
FHH-Chr 14BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.22 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15264 |
381 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
9 |
|
57.71 |
ml/min |
3.56 |
10.68 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14542 |
381 |
FHH-Chr 14BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
4 |
|
0.49 |
mg/dl |
0.05 |
0.09 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52251 |
482 |
FHH-Chr 14BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
5 |
|
4.35 |
ng/ml/h |
1.32 |
2.96 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52886 |
482 |
FHH-Chr 14BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
6 |
|
156.03 |
mmHg |
5.11 |
12.52 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52539 |
482 |
FHH-Chr 14BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77 days-91 days |
8 |
|
4.83 |
g/dl |
0.1 |
0.28 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37200 |
401 |
FHH-Chr 14BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77 days-91 days |
8 |
|
3.37 |
x 1000 cells/ul |
0.33 |
0.94 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36871 |
401 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
30.53 |
ml/min |
1.58 |
5.0 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20250 |
381 |
FHH-Chr 14BN/Mcwi |
serum chloride level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77 days-91 days |
8 |
|
111.63 |
mmol/l |
0.71 |
2.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39148 |
401 |
FHH-Chr 14BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
137.23 |
% |
9.0 |
28.45 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54368 |
381 |
FHH-Chr 14BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77 days-91 days |
8 |
|
24.63 |
mmol/l |
1.15 |
3.25 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42992 |
401 |
FHH-Chr 14BN/Mcwi |
blood neutrophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77 days-91 days |
8 |
|
0.87 |
x 1000 cells/ul |
0.15 |
0.42 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43255 |
401 |
FHH-Chr 14BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
132.48 |
% |
10.62 |
33.58 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54457 |
381 |
FHH-Chr 14BN/Mcwi |
total white blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77 days-91 days |
8 |
|
5.71 |
x 1000 cells/ul |
0.43 |
1.23 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40957 |
401 |
FHH-Chr 14BN/Mcwi |
serum urea nitrogen level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77 days-91 days |
8 |
|
27.63 |
mg/dl |
2.1 |
5.93 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40869 |
401 |
FHH-Chr 14BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77 days-91 days |
8 |
|
143.5 |
mg/dl |
4.35 |
12.31 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41196 |
401 |
FHH-Chr 14BN/Mcwi |
heart wet weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
9 |
|
0.52 |
g |
0.04 |
0.13 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45436 |
461 |
FHH-Chr 14BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
7.66 |
x 10E6 cells/ul |
0.2 |
0.58 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41971 |
401 |
FHH-Chr 14BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
1.42 |
g/mg |
0.14 |
0.44 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55781 |
522 |
FHH-Chr 14BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
-7.25 |
null |
0.1 |
0.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55618 |
522 |
FHH-Chr 14BN/Mcwi |
FAPGG metabolism-surface area product |
air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
5 |
|
59.0 |
ml/min/kg |
5.23 |
11.69 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58030 |
526 |
FHH-Chr 14BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
8 |
|
0.1 |
mmHg x min x kg x ml-1 |
0.01 |
0.03 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59874 |
526 |
FHH-Chr 14BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
4 |
|
8.09 |
ml/min/g |
1.77 |
3.54 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44749 |
461 |
FHH-Chr 14BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
|
6.86 |
ml/min/g |
0.93 |
2.29 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44759 |
461 |
FHH-Chr 14BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
4 |
|
17.65 |
ml/min/g |
3.77 |
7.54 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46684 |
461 |
FHH-Chr 14BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
6 |
|
182.37 |
beats/min |
22.03 |
53.97 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48986 |
461 |
FHH-Chr 14BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
171.76 |
breaths/min |
5.11 |
16.15 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16942 |
381 |
FHH-Chr 14BN/Mcwi |
serum total cholesterol level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77 days-91 days |
8 |
|
69.13 |
mg/dl |
2.86 |
8.1 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37128 |
401 |
FHH-Chr 14BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
115.45 |
% |
3.71 |
11.72 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18585 |
381 |
FHH-Chr 14BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
7 |
|
234.57 |
beats/min |
10.62 |
28.09 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48228 |
461 |
FHH-Chr 14BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
6 |
|
0.68 |
IU/g |
0.21 |
0.52 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47441 |
461 |
FHH-Chr 14BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
6 |
|
0.32 |
IU/g |
0.09 |
0.23 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47299 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
|
22.9 |
mmHg |
7.87 |
19.29 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45311 |
461 |
FHH-Chr 14BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
-7.26 |
null |
0.06 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55602 |
522 |
FHH-Chr 14BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77 days-91 days |
8 |
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42869 |
401 |
FHH-Chr 14BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77 days-91 days |
8 |
|
24.25 |
mmol/l |
1.18 |
3.33 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42976 |
401 |
FHH-Chr 14BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49 days-63 days |
4 |
|
2.93 |
% |
0.37 |
0.75 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49729 |
461 |
FHH-Chr 14BN/Mcwi |
heart wet weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
9 |
|
0.57 |
g |
0.05 |
0.14 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45446 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
5 |
|
65.12 |
mmHg |
6.18 |
13.83 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45545 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
156.29 |
% |
8.5 |
26.89 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53666 |
381 |
FHH-Chr 14BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77 days-91 days |
10 |
|
0.29 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57887 |
526 |
FHH-Chr 14BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.21 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15428 |
381 |
FHH-Chr 14BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
6 |
|
120.21 |
mg/d |
42.95 |
105.22 |
automated urine total protein analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52102 |
482 |
FHH-Chr 14BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
7 |
|
2.19 |
ng/ml/h |
0.69 |
1.83 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52902 |
482 |
FHH-Chr 14BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
8 |
|
1.55 |
ml/min |
0.16 |
0.45 |
urine creatinine analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52363 |
482 |
FHH-Chr 14BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
9 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
200.7 |
% |
21.27 |
63.81 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14240 |
381 |
FHH-Chr 14BN/Mcwi |
body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
9 |
|
37.33 |
degrees C |
0.15 |
0.45 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13601 |
381 |
FHH-Chr 14BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82 days-99 days |
10 |
|
146.6 |
g |
2.7 |
8.4 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Dyets |
17848 |
381 |
FHH-Chr 14BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
33.08 |
g/dl |
0.16 |
0.46 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37314 |
401 |
FHH-Chr 14BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77 days-91 days |
8 |
|
9.23 |
mg/dl |
0.1 |
0.27 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36761 |
401 |
FHH-Chr 14BN/Mcwi |
time to peak heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
6 |
|
1179.56 |
s |
29.65 |
72.63 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50268 |
461 |
FHH-Chr 14BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49 days-63 days |
7 |
|
9.62 |
% |
2.33 |
6.15 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49427 |
461 |
FHH-Chr 14BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
body mass |
female |
49 days-63 days |
9 |
|
84.3 |
g |
7.4 |
22.1 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49495 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
|
69.74 |
mmHg |
11.13 |
27.26 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49929 |
461 |
FHH-Chr 14BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77 days-91 days |
8 |
|
0.78 |
x 1000 cells/ul |
0.1 |
0.29 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38898 |
401 |
FHH-Chr 14BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
body mass |
male |
77 days-91 days |
10 |
|
116.3 |
g |
5.3 |
16.7 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59103 |
526 |
FHH-Chr 14BN/Mcwi |
blood eosinophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77 days-91 days |
8 |
|
0.05 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41688 |
401 |
FHH-Chr 14BN/Mcwi |
percent change in left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
92.41 |
% |
7.05 |
17.26 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48797 |
461 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
9 |
|
28.71 |
ml/min |
3.65 |
10.96 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16189 |
381 |
FHH-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
53.84 |
% |
4.3 |
10.53 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47118 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
4 |
|
4.82 |
mmHg |
0.35 |
0.7 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47228 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
|
5.25 |
mmHg |
0.32 |
0.79 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47238 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
131.7 |
% |
10.98 |
26.89 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44959 |
461 |
FHH-Chr 14BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
111.4 |
breaths/min |
3.74 |
11.84 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14966 |
381 |
FHH-Chr 14BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
110.08 |
% |
5.25 |
16.59 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54018 |
381 |
FHH-Chr 14BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
139.4 |
% |
5.89 |
18.63 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54251 |
381 |
FHH-Chr 14BN/Mcwi |
percent change in ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
138.21 |
% |
7.13 |
22.54 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13711 |
381 |
FHH-Chr 14BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.21 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13954 |
381 |
FHH-Chr 14BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
153.99 |
breaths/min |
5.03 |
15.9 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17142 |
381 |
FHH-Chr 14BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
104.41 |
% |
4.44 |
14.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53785 |
381 |
FHH-Chr 14BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
129.31 |
breaths/min |
5.24 |
16.58 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18441 |
381 |
FHH-Chr 14BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
7 |
|
226.57 |
beats/min |
14.2 |
37.57 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48976 |
461 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
29.87 |
ml/min |
3.14 |
9.94 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20239 |
381 |
FHH-Chr 14BN/Mcwi |
serum aspartate aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77 days-91 days |
8 |
|
112.0 |
U/l |
9.98 |
28.22 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42811 |
401 |
FHH-Chr 14BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77 days-91 days |
8 |
|
0.2 |
mg/dl |
0.0 |
0.0 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42632 |
401 |
FHH-Chr 14BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77 days-91 days |
8 |
|
4.43 |
x 1000 cells/ul |
0.45 |
1.27 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39887 |
401 |
FHH-Chr 14BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
9 |
|
135.9 |
% |
7.5 |
22.49 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54467 |
381 |
FHH-Chr 14BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77 days-91 days |
8 |
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42885 |
401 |
FHH-Chr 14BN/Mcwi |
serum alanine aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77 days-91 days |
8 |
|
97.25 |
U/l |
9.68 |
27.38 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40755 |
401 |
FHH-Chr 14BN/Mcwi |
serum globulin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77 days-91 days |
8 |
|
1.76 |
g/dl |
0.05 |
0.13 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
40591 |
401 |
FHH-Chr 14BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77 days-91 days |
10 |
|
1.06 |
g/kg |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59440 |
526 |
FHH-Chr 14BN/Mcwi |
serum phosphate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77 days-91 days |
8 |
|
10.54 |
mg/dl |
0.54 |
1.52 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37625 |
401 |
FHH-Chr 14BN/Mcwi |
serum phosphate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77 days-91 days |
8 |
|
9.19 |
mg/dl |
0.38 |
1.08 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37635 |
401 |
FHH-Chr 14BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77 days-91 days |
8 |
|
68.38 |
U/l |
5.11 |
14.46 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37693 |
401 |
FHH-Chr 14BN/Mcwi |
serum urea nitrogen level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77 days-91 days |
8 |
|
29.75 |
mg/dl |
2.6 |
7.36 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40859 |
401 |
FHH-Chr 14BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
7 |
|
0.51 |
null |
0.06 |
0.15 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59759 |
526 |
FHH-Chr 14BN/Mcwi |
blood hemoglobin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
16.99 |
g/dl |
0.39 |
1.1 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38009 |
401 |
FHH-Chr 14BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77 days-91 days |
8 |
|
78.75 |
U/l |
4.51 |
12.76 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37709 |
401 |
FHH-Chr 14BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
4 |
|
41.83 |
mmHg |
5.18 |
10.36 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46448 |
461 |
FHH-Chr 14BN/Mcwi |
serum glucose level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77 days-91 days |
7 |
|
136.14 |
mg/dl |
3.73 |
9.87 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38561 |
401 |
FHH-Chr 14BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
7 |
|
1315.29 |
s |
94.82 |
250.87 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46579 |
461 |
FHH-Chr 14BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77 days-91 days |
10 |
|
0.31 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57903 |
526 |
FHH-Chr 14BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
78.0 |
% |
13.32 |
42.13 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54757 |
522 |
FHH-Chr 14BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
7 |
|
38.0 |
mmHg |
9.49 |
25.11 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48064 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
|
75.58 |
mmHg |
5.73 |
15.16 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44846 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
|
63.82 |
mmHg |
7.85 |
20.78 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
|
46781 |
461 |
FHH-Chr 14BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49 days-63 days |
9 |
|
135.7 |
g |
11.2 |
33.5 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47806 |
461 |
FHH-Chr 14BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
7 |
|
30.48 |
mEq/d |
3.7 |
9.8 |
flame atomic emission spectrometry |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52804 |
482 |
FHH-Chr 14BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
88.12 |
% |
12.72 |
31.15 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46360 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
|
36.54 |
mmHg |
4.8 |
12.69 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47732 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
114.09 |
% |
9.53 |
25.22 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44949 |
461 |
FHH-Chr 14BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
7 |
|
1.5 |
g/mg |
0.18 |
0.48 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55765 |
522 |
FHH-Chr 14BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
|
68.7 |
mmHg |
7.25 |
19.19 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45535 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
4 |
|
82.31 |
mmHg |
13.08 |
26.17 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48655 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
|
46.84 |
mmHg |
6.37 |
15.61 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46458 |
461 |
FHH-Chr 14BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77 days-91 days |
10 |
|
1.1 |
g/kg |
0.06 |
0.18 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59456 |
526 |
FHH-Chr 14BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
7 |
|
17.62 |
IU/g |
1.46 |
3.85 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48841 |
461 |
FHH-Chr 14BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
-7.73 |
null |
0.06 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55268 |
522 |
FHH-Chr 14BN/Mcwi |
lung dry weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77 days-91 days |
10 |
|
1.55 |
g/kg |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59698 |
526 |
FHH-Chr 14BN/Mcwi |
FAPGG metabolism-surface area product |
air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
9 |
|
53.12 |
ml/min/kg |
3.89 |
11.67 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58040 |
526 |
FHH-Chr 14BN/Mcwi |
serum potassium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77 days-91 days |
8 |
|
4.61 |
mmol/l |
0.36 |
1.01 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38097 |
401 |
FHH-Chr 14BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
134.31 |
% |
5.1 |
16.12 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54117 |
381 |
FHH-Chr 14BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
9 |
|
144.3 |
% |
8.49 |
25.48 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54127 |
381 |
FHH-Chr 14BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
0.22 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13965 |
381 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
42.62 |
ml/min |
2.81 |
8.9 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20792 |
381 |
FHH-Chr 14BN/Mcwi |
serum alkaline phosphatase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77 days-91 days |
8 |
|
394.63 |
U/l |
23.83 |
67.4 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36410 |
401 |
FHH-Chr 14BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
172.82 |
breaths/min |
12.66 |
40.03 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18307 |
381 |
FHH-Chr 14BN/Mcwi |
serum total protein level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77 days-91 days |
8 |
|
4.74 |
g/dl |
0.12 |
0.34 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37003 |
401 |
FHH-Chr 14BN/Mcwi |
serum total cholesterol level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77 days-91 days |
8 |
|
68.25 |
mg/dl |
4.17 |
11.79 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37138 |
401 |
FHH-Chr 14BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
33.33 |
g/dl |
0.18 |
0.5 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37330 |
401 |
FHH-Chr 14BN/Mcwi |
serum calcium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77 days-91 days |
8 |
|
8.85 |
mg/dl |
0.12 |
0.33 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36665 |
401 |
FHH-Chr 14BN/Mcwi |
heart contraction pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
4 |
|
17.5 |
mmHg |
4.09 |
8.19 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50028 |
461 |
FHH-Chr 14BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
51.7 |
% |
1.2 |
3.4 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39022 |
401 |
FHH-Chr 14BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
53.45 |
% |
1.15 |
3.24 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39032 |
401 |
FHH-Chr 14BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77 days-91 days |
7 |
|
2.25 |
mg/kg |
0.56 |
1.49 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59151 |
526 |
FHH-Chr 14BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77 days-91 days |
8 |
|
106.75 |
mmol/l |
0.7 |
1.98 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39992 |
401 |
FHH-Chr 14BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
9 |
|
149.55 |
% |
10.45 |
31.36 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53676 |
381 |
FHH-Chr 14BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77 days-91 days |
8 |
|
140.38 |
mg/dl |
3.95 |
11.19 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41180 |
401 |
FHH-Chr 14BN/Mcwi |
serum potassium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77 days-91 days |
8 |
|
5.15 |
mmol/l |
0.24 |
0.69 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38107 |
401 |
FHH-Chr 14BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
9 |
|
0.14 |
mmHg x min x kg x ml-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59588 |
526 |
FHH-Chr 14BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
40.2 |
% |
0.95 |
2.69 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41304 |
401 |
FHH-Chr 14BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77 days-91 days |
8 |
|
1.84 |
g/dl |
0.04 |
0.11 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
41029 |
401 |
FHH-Chr 14BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77 days-91 days |
8 |
|
53.88 |
fl |
0.17 |
0.47 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38633 |
401 |
FHH-Chr 14BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77 days-91 days |
8 |
|
52.49 |
fl |
0.22 |
0.63 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38649 |
401 |
FHH-Chr 14BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
7.38 |
x 10E6 cells/ul |
0.17 |
0.49 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41955 |
401 |
FHH-Chr 14BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
130.5 |
g |
6.8 |
21.6 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55410 |
522 |
FHH-Chr 14BN/Mcwi |
body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
10 |
|
37.31 |
degrees C |
0.18 |
0.57 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16614 |
381 |
FHH-Chr 14BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77 days-91 days |
10 |
|
0.48 |
null |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58774 |
526 |
FHH-Chr 14BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
144.4 |
g |
7.2 |
22.7 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55162 |
522 |
FHH-Chr 14BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
168.7 |
g |
5.4 |
17.2 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55176 |
522 |
FHH-Chr 14BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
0.12 |
mmHg x min x kg x ml-1 |
0.01 |
0.03 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59890 |
526 |
FHH-Chr 14BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
4 |
|
15.19 |
IU/g |
1.83 |
3.66 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45952 |
461 |
FHH-Chr 14BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
6 |
|
15.63 |
IU/g |
1.38 |
3.38 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45962 |
461 |
FHH-Chr 14BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
|
8.16 |
ml/min/g |
0.29 |
0.78 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46901 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
5 |
|
60.93 |
mmHg |
6.18 |
13.83 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
|
46791 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
|
76.59 |
mmHg |
8.35 |
20.46 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44856 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
4 |
|
87.13 |
mmHg |
12.99 |
25.99 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45760 |
461 |
FHH-Chr 14BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
12.66 |
ml/min/g |
1.06 |
2.99 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46694 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
|
28.17 |
mmHg |
4.32 |
10.57 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47742 |
461 |
FHH-Chr 14BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
0.21 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15275 |
381 |
FHH-Chr 14BN/Mcwi |
absolute change in body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
9 |
|
0.24 |
degrees C |
0.08 |
0.23 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15711 |
381 |
FHH-Chr 14BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
8 |
|
0.43 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52267 |
482 |
FHH-Chr 14BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
4 |
|
1.09 |
ml/min |
0.1 |
0.21 |
urine creatinine analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52347 |
482 |
FHH-Chr 14BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
8 |
|
139.15 |
mg/d |
34.34 |
97.13 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52410 |
482 |
FHH-Chr 14BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82 days-99 days |
10 |
|
217.9 |
g |
8.7 |
27.6 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Dyets |
17859 |
381 |
FHH-Chr 14BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
0.21 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18024 |
381 |
FHH-Chr 14BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
9 |
|
0.69 |
g |
0.04 |
0.13 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49091 |
461 |
FHH-Chr 14BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
9 |
|
0.7 |
g |
0.08 |
0.23 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49101 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
5 |
|
4.19 |
mmHg |
0.31 |
0.7 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49218 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
9 |
%change=VE during 2-3 min hypercapnia/control during standard conditions |
217.4 |
% |
22.08 |
66.25 |
stop flow air displacement plethysmography |
0 |
0 |
|
|
Moms and pups used in studies were fed Teklad |
19253 |
381 |
FHH-Chr 14BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
169.41 |
breaths/min |
8.23 |
26.03 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18296 |
381 |
FHH-Chr 14BN/Mcwi |
absolute change in body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
0.16 |
degrees C |
0.16 |
0.51 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20340 |
381 |
FHH-Chr 14BN/Mcwi |
serum sodium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77 days-91 days |
8 |
|
145.63 |
mmol/l |
0.46 |
1.3 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39419 |
401 |
FHH-Chr 14BN/Mcwi |
mean corpuscular hemoglobin |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
18.64 |
pg |
0.08 |
0.21 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42576 |
401 |
FHH-Chr 14BN/Mcwi |
red blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
9.28 |
x 10E6 cells/ul |
0.25 |
0.7 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39278 |
401 |
FHH-Chr 14BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77 days-91 days |
8 |
|
3.95 |
x 1000 cells/ul |
0.3 |
0.84 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39871 |
401 |
FHH-Chr 14BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
131.67 |
% |
5.51 |
17.41 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54358 |
381 |
FHH-Chr 14BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77 days-91 days |
8 |
|
15.75 |
mmol/l |
0.45 |
1.28 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43133 |
401 |
FHH-Chr 14BN/Mcwi |
blood neutrophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77 days-91 days |
8 |
|
1.11 |
x 1000 cells/ul |
0.15 |
0.43 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43265 |
401 |
FHH-Chr 14BN/Mcwi |
plasma creatinine level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77 days-91 days |
8 |
|
0.3 |
mg/dl |
0.03 |
0.08 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39617 |
401 |
FHH-Chr 14BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
female |
77 days-91 days |
8 |
|
0.05 |
mmHg-1 |
0.01 |
0.03 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59344 |
526 |
FHH-Chr 14BN/Mcwi |
serum alanine aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77 days-91 days |
8 |
|
83.38 |
U/l |
4.4 |
12.43 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40745 |
401 |
FHH-Chr 14BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
25.55 |
ml/min/kg |
2.46 |
6.96 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57841 |
526 |
FHH-Chr 14BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
-6.92 |
null |
0.13 |
0.4 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56908 |
522 |
FHH-Chr 14BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
|
5.07 |
ml/min/g |
0.68 |
1.68 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46242 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
84.53 |
% |
8.95 |
21.93 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48447 |
461 |
FHH-Chr 14BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
7 |
|
0.36 |
IU/g |
0.07 |
0.19 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47283 |
461 |
FHH-Chr 14BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
6 |
|
204.34 |
beats/min |
11.08 |
27.13 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45189 |
461 |
FHH-Chr 14BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
9 |
|
170.5 |
breaths/min |
6.62 |
19.85 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16953 |
381 |
FHH-Chr 14BN/Mcwi |
serum total protein level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77 days-91 days |
8 |
|
4.78 |
g/dl |
0.1 |
0.29 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36993 |
401 |
FHH-Chr 14BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
%change=VE during 2-3 min hypercapnia/control during standard conditions |
208.68 |
% |
11.33 |
35.82 |
stop flow air displacement plethysmography |
0 |
0 |
|
|
Moms and pups used in studies were fed Teklad |
19242 |
381 |
FHH-Chr 14BN/Mcwi |
heart weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
9 |
|
6.5 |
g/kg |
0.53 |
1.58 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45609 |
461 |
FHH-Chr 14BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
|
7.57 |
ml/min/g |
0.52 |
1.28 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46911 |
461 |
FHH-Chr 14BN/Mcwi |
serum aspartate aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77 days-91 days |
8 |
|
96.25 |
U/l |
3.6 |
10.19 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42801 |
401 |
FHH-Chr 14BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.28 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16504 |
381 |
FHH-Chr 14BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
0.58 |
E-7mole |
0.08 |
0.25 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55871 |
522 |
FHH-Chr 14BN/Mcwi |
heart weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
9 |
|
6.28 |
g/kg |
0.43 |
1.28 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45593 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
4 |
post-ischemic value/pre-ischemic value x 100% |
79.11 |
% |
8.13 |
16.25 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48787 |
461 |
FHH-Chr 14BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
male |
77 days-91 days |
8 |
|
0.04 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59360 |
526 |
FHH-Chr 14BN/Mcwi |
red blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
8.87 |
x 10E6 cells/ul |
0.21 |
0.61 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39268 |
401 |
FHH-Chr 14BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
39.74 |
% |
0.97 |
2.75 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41288 |
401 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
48.67 |
ml/min |
2.35 |
7.44 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14531 |
381 |
FHH-Chr 14BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
8 |
|
260.83 |
mg/d |
72.11 |
203.96 |
automated urine total protein analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52118 |
482 |
FHH-Chr 14BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
8 |
|
2.67 |
mEq/d |
0.79 |
2.22 |
flame atomic emission spectrometry |
|
0 |
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52316 |
482 |
FHH-Chr 14BN/Mcwi |
body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
37.27 |
degrees C |
0.17 |
0.54 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13590 |
381 |
FHH-Chr 14BN/Mcwi |
serum alkaline phosphatase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77 days-91 days |
8 |
|
405.75 |
U/l |
24.89 |
70.41 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36420 |
401 |
FHH-Chr 14BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77 days-91 days |
8 |
|
4.89 |
g/dl |
0.1 |
0.28 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37184 |
401 |
FHH-Chr 14BN/Mcwi |
mean corpuscular hemoglobin |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
18.31 |
pg |
0.12 |
0.33 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42586 |
401 |
FHH-Chr 14BN/Mcwi |
blood monocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77 days-91 days |
8 |
|
0.22 |
x 1000 cells/ul |
0.05 |
0.15 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39705 |
401 |
FHH-Chr 14BN/Mcwi |
mean corpuscular hemoglobin concentration |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
31.75 |
g/dl |
0.16 |
0.45 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39818 |
401 |
FHH-Chr 14BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77 days-91 days |
6 |
|
4.44 |
mg/kg |
1.7 |
4.17 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58937 |
526 |
FHH-Chr 14BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
0.56 |
null |
0.05 |
0.15 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59775 |
526 |
FHH-Chr 14BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77 days-91 days |
8 |
|
8.88 |
mg/dl |
0.28 |
0.8 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37813 |
401 |
FHH-Chr 14BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77 days-91 days |
8 |
|
8.86 |
mg/dl |
0.25 |
0.71 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37829 |
401 |
FHH-Chr 14BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
5 |
|
0.14 |
mmHg x min x kg x ml-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59578 |
526 |
FHH-Chr 14BN/Mcwi |
lung dry weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77 days-91 days |
9 |
|
1.81 |
g/kg |
0.09 |
0.27 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59688 |
526 |
FHH-Chr 14BN/Mcwi |
percent change in left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
32.87 |
% |
7.74 |
18.97 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48568 |
461 |
FHH-Chr 14BN/Mcwi |
serum total bilirubin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77 days-91 days |
8 |
|
0.11 |
mg/dl |
0.01 |
0.04 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41899 |
401 |
FHH-Chr 14BN/Mcwi |
percent change in left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
4 |
post-ischemic value/pre-ischemic value x 100% |
32.27 |
% |
6.26 |
12.53 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48558 |
461 |
FHH-Chr 14BN/Mcwi |
serum glucose level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77 days-91 days |
8 |
|
152.63 |
mg/dl |
8.09 |
22.87 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38571 |
401 |
FHH-Chr 14BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54883 |
522 |
FHH-Chr 14BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
male |
77 days-91 days |
9 |
|
0.02 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58530 |
526 |
FHH-Chr 14BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
1.74 |
E-7mole |
0.66 |
1.98 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56513 |
522 |
FHH-Chr 14BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77 days-91 days |
7 |
|
3.38 |
mg/kg |
0.87 |
2.31 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58947 |
526 |
FHH-Chr 14BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
9 |
|
5.13 |
g/kg |
0.18 |
0.55 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46984 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
|
77.74 |
mmHg |
12.99 |
31.81 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45770 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
4 |
|
24.32 |
mmHg |
2.27 |
4.55 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45301 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
9 |
|
146.97 |
% |
13.37 |
40.1 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54261 |
381 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
9 |
|
53.14 |
ml/min |
3.79 |
11.36 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20803 |
381 |
FHH-Chr 14BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
120.57 |
% |
6.67 |
21.1 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53795 |
381 |
FHH-Chr 14BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
9 |
|
37.09 |
degrees C |
0.13 |
0.39 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19111 |
381 |
FHH-Chr 14BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77 days-91 days |
8 |
|
9.51 |
mg/dl |
0.13 |
0.36 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36745 |
401 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
35.66 |
ml/min |
3.32 |
10.48 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18693 |
381 |
FHH-Chr 14BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
7 |
|
1119.29 |
s |
74.89 |
198.15 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50150 |
461 |
FHH-Chr 14BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77 days-91 days |
8 |
|
91.25 |
U/l |
6.68 |
18.88 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42403 |
401 |
FHH-Chr 14BN/Mcwi |
serum albumin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77 days-91 days |
8 |
|
3.06 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42264 |
401 |
FHH-Chr 14BN/Mcwi |
serum globulin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77 days-91 days |
8 |
|
1.71 |
g/dl |
0.05 |
0.16 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
40581 |
401 |
FHH-Chr 14BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
51.7 |
% |
1.2 |
3.4 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59288 |
526 |
FHH-Chr 14BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77 days-91 days |
8 |
|
81.13 |
mg/dl |
2.51 |
7.1 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38435 |
401 |
FHH-Chr 14BN/Mcwi |
blood lymphocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77 days-91 days |
8 |
|
4.72 |
x 1000 cells/ul |
0.41 |
1.17 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41544 |
401 |
FHH-Chr 14BN/Mcwi |
plasma anion gap |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77 days-91 days |
8 |
|
17.25 |
mmol/l |
0.53 |
1.49 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38302 |
401 |
FHH-Chr 14BN/Mcwi |
blood eosinophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77 days-91 days |
8 |
|
0.05 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41678 |
401 |
FHH-Chr 14BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
40.2 |
% |
0.95 |
2.69 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57489 |
526 |
FHH-Chr 14BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
5 |
|
28.69 |
ml/min/kg |
2.06 |
4.61 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57831 |
526 |
FHH-Chr 14BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
37.19 |
degrees C |
0.16 |
0.5 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16843 |
381 |
FHH-Chr 14BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
10 |
|
37.27 |
degrees C |
0.16 |
0.49 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16854 |
381 |
FHH-Chr 14BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
5 |
|
0.49 |
null |
0.03 |
0.07 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58144 |
526 |
FHH-Chr 14BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
0.47 |
null |
0.05 |
0.15 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58154 |
526 |
FHH-Chr 14BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
-6.83 |
null |
0.09 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56892 |
522 |
FHH-Chr 14BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
76.89 |
% |
4.4 |
13.19 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57217 |
522 |
FHH-Chr 14BN/Mcwi |
percent change in heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
4 |
post-ischemic value/pre-ischemic value x 100% |
102.69 |
% |
11.67 |
23.35 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48326 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
4 |
post-ischemic value/pre-ischemic value x 100% |
49.03 |
% |
9.9 |
19.8 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47108 |
461 |
FHH-Chr 14BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
37.1 |
degrees C |
0.18 |
0.57 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19100 |
381 |
FHH-Chr 14BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
115.69 |
% |
8.82 |
27.89 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18574 |
381 |
FHH-Chr 14BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
4 |
|
213.13 |
beats/min |
13.85 |
27.7 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45179 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
96.86 |
% |
5.42 |
14.33 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48437 |
461 |
FHH-Chr 14BN/Mcwi |
body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
37.35 |
degrees C |
0.22 |
0.71 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16603 |
381 |
FHH-Chr 14BN/Mcwi |
plasma creatinine level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77 days-91 days |
8 |
|
0.26 |
mg/dl |
0.03 |
0.07 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39607 |
401 |
FHH-Chr 14BN/Mcwi |
blood monocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77 days-91 days |
8 |
|
0.27 |
x 1000 cells/ul |
0.07 |
0.19 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39715 |
401 |
FHH-Chr 14BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
body mass |
male |
49 days-63 days |
9 |
|
88.4 |
g |
6.0 |
18.1 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49511 |
461 |
FHH-Chr 14BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
8 |
|
213.22 |
beats/min |
17.47 |
49.41 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47623 |
461 |
FHH-Chr 14BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77 days-91 days |
8 |
|
0.1 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40280 |
401 |
FHH-Chr 14BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
6 |
|
1121.33 |
s |
87.97 |
215.49 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50160 |
461 |
FHH-Chr 14BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77 days-91 days |
10 |
|
0.53 |
null |
0.02 |
0.08 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58764 |
526 |
FHH-Chr 14BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
1.76 |
E-7mole |
0.37 |
1.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56497 |
522 |
FHH-Chr 14BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
|
72.49 |
mmHg |
13.13 |
32.16 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48665 |
461 |
FHH-Chr 14BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
6 |
|
16.96 |
IU/g |
0.69 |
1.68 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48852 |
461 |
FHH-Chr 14BN/Mcwi |
serum bicarbonate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77 days-91 days |
8 |
|
20.75 |
mmol/l |
0.65 |
1.83 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42093 |
401 |
FHH-Chr 14BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
8 |
|
-7.75 |
null |
0.06 |
0.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55252 |
522 |
FHH-Chr 14BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
11.68 |
ml/min/kg |
1.37 |
3.88 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59996 |
526 |
FHH-Chr 14BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
105.24 |
% |
4.43 |
14.02 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53917 |
381 |
FHH-Chr 14BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
126.53 |
breaths/min |
5.64 |
17.83 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18452 |
381 |
FHH-Chr 14BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
|
4.89 |
mmHg |
0.72 |
1.91 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49208 |
461 |
FHH-Chr 14BN/Mcwi |
absolute change in body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
10 |
|
0.04 |
degrees C |
0.12 |
0.37 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20351 |
381 |
FHH-Chr 14BN/Mcwi |
serum sodium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77 days-91 days |
8 |
|
145.0 |
mmol/l |
0.68 |
1.93 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39429 |
401 |
FHH-Chr 14BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77 days-91 days |
8 |
|
0.2 |
mg/dl |
0.0 |
0.0 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42648 |
401 |
FHH-Chr 14BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77 days-91 days |
8 |
|
15.63 |
mmol/l |
0.63 |
1.77 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43117 |
401 |
FHH-Chr 14BN/Mcwi |
mean corpuscular hemoglobin concentration |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
31.96 |
g/dl |
0.17 |
0.48 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39808 |
401 |
FHH-Chr 14BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
53.45 |
% |
1.15 |
3.24 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59298 |
526 |
FHH-Chr 14BN/Mcwi |
total white blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77 days-91 days |
8 |
|
6.15 |
x 1000 cells/ul |
0.49 |
1.38 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40967 |
401 |
FHH-Chr 14BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77 days-91 days |
8 |
|
79.63 |
mg/dl |
2.11 |
5.97 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38419 |
401 |
FHH-Chr 14BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77 days-91 days |
8 |
|
18.75 |
mg/dl |
2.04 |
5.78 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41738 |
401 |
FHH-Chr 14BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
1.18 |
g/mg |
0.12 |
0.39 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57327 |
522 |
FHH-Chr 14BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
39.74 |
% |
0.97 |
2.75 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57473 |
526 |
FHH-Chr 14BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
0.61 |
E-7mole |
0.09 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55887 |
522 |
FHH-Chr 14BN/Mcwi |
FAPGG metabolism-surface area product |
FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
40.15 |
ml/min/kg |
5.45 |
15.41 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58229 |
526 |
FHH-Chr 14BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
73.11 |
% |
3.67 |
11.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57201 |
522 |
FHH-Chr 14BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
|
6.74 |
ml/min/g |
1.98 |
5.24 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46232 |
461 |
FHH-Chr 14BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
9 |
|
117.53 |
breaths/min |
7.75 |
23.26 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14977 |
381 |
FHH-Chr 14BN/Mcwi |
absolute change in body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
0.17 |
degrees C |
0.06 |
0.2 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15700 |
381 |
FHH-Chr 14BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
6 |
|
23.14 |
mEq/d |
3.44 |
8.42 |
flame atomic emission spectrometry |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52788 |
482 |
FHH-Chr 14BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
6 |
|
2.0 |
mEq/d |
0.31 |
0.75 |
flame atomic emission spectrometry |
|
0 |
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52300 |
482 |
FHH-Chr 14BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
6 |
|
424.87 |
beats/min |
7.24 |
17.73 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52492 |
482 |
FHH-Chr 14BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
8 |
|
405.62 |
beats/min |
14.94 |
42.25 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52508 |
482 |
FHH-Chr 14BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
8 |
|
164.54 |
mmHg |
7.86 |
22.23 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52555 |
482 |
FHH-Chr 14BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
184.56 |
% |
16.96 |
53.64 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14229 |
381 |
FHH-Chr 14BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77 days-91 days |
8 |
|
3.29 |
x 1000 cells/ul |
0.26 |
0.72 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36855 |
401 |
FHH-Chr 14BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77 days-91 days |
8 |
|
245.63 |
U/l |
16.79 |
47.48 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37436 |
401 |
FHH-Chr 14BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77 days-91 days |
8 |
|
142.63 |
mmol/l |
0.73 |
2.07 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36476 |
401 |
FHH-Chr 14BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77 days-91 days |
8 |
|
143.63 |
mmol/l |
0.98 |
2.77 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36492 |
401 |
FHH-Chr 14BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49 days-63 days |
5 |
|
3.86 |
% |
0.78 |
1.75 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49739 |
461 |
FHH-Chr 14BN/Mcwi |
time to peak heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
4 |
|
1097.42 |
s |
143.23 |
286.45 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50258 |
461 |
FHH-Chr 14BN/Mcwi |
time to onset of heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
4 |
|
917.38 |
s |
158.14 |
316.27 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49330 |
461 |
FHH-Chr 14BN/Mcwi |
mean corpuscular volume |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77 days-91 days |
8 |
|
57.73 |
fl |
0.38 |
1.08 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38786 |
401 |
FHH-Chr 14BN/Mcwi |
serum albumin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77 days-91 days |
8 |
|
2.98 |
g/dl |
0.1 |
0.29 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42274 |
401 |
FHH-Chr 14BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77 days-91 days |
8 |
|
99.5 |
U/l |
5.6 |
15.85 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42419 |
401 |
FHH-Chr 14BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77 days-91 days |
8 |
|
4.21 |
mmol/l |
0.18 |
0.51 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43329 |
401 |
FHH-Chr 14BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77 days-91 days |
8 |
|
2.17 |
mg/kg |
0.56 |
1.58 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59167 |
526 |
FHH-Chr 14BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77 days-91 days |
8 |
|
3.14 |
g/dl |
0.08 |
0.23 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40393 |
401 |
FHH-Chr 14BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77 days-91 days |
8 |
|
2.99 |
g/dl |
0.08 |
0.24 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40409 |
401 |
FHH-Chr 14BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
13.15 |
g/dl |
0.28 |
0.8 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40088 |
401 |
FHH-Chr 14BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
13.39 |
g/dl |
0.29 |
0.82 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40104 |
401 |
FHH-Chr 14BN/Mcwi |
blood hemoglobin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
16.52 |
g/dl |
0.41 |
1.15 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37999 |
401 |
FHH-Chr 14BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77 days-91 days |
8 |
|
0.08 |
x 1000 cells/ul |
0.02 |
0.04 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41390 |
401 |
FHH-Chr 14BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77 days-91 days |
8 |
|
0.03 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41406 |
401 |
FHH-Chr 14BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
6 |
|
1269.33 |
s |
89.06 |
218.15 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46589 |
461 |
FHH-Chr 14BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
4 |
|
212.65 |
beats/min |
17.6 |
35.21 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47613 |
461 |
FHH-Chr 14BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
120.3 |
g |
7.0 |
22.2 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55396 |
522 |
FHH-Chr 14BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
81.78 |
% |
4.36 |
13.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54773 |
522 |
FHH-Chr 14BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
-7.99 |
null |
0.13 |
0.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56082 |
522 |
FHH-Chr 14BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54667 |
522 |
FHH-Chr 14BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
8 |
|
20.09 |
ml/min/kg |
2.06 |
5.83 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58609 |
526 |
FHH-Chr 14BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
9 |
|
5.48 |
g/kg |
0.14 |
0.43 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46968 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
|
39.04 |
mmHg |
4.85 |
12.84 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47942 |
461 |
FHH-Chr 14BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
6 |
|
23.23 |
mmHg |
2.26 |
5.54 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48074 |
461 |
FHH-Chr 14BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49 days-63 days |
9 |
|
125.1 |
g |
7.8 |
23.4 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47790 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
104.43 |
% |
4.94 |
15.62 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53927 |
381 |
FHH-Chr 14BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
97.52 |
% |
4.43 |
14.02 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54028 |
381 |
FHH-Chr 14BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77 days-91 days |
8 |
|
356.38 |
U/l |
22.19 |
62.77 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37452 |
401 |
FHH-Chr 14BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
134.21 |
breaths/min |
6.41 |
20.26 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14825 |
381 |
FHH-Chr 14BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
149.55 |
breaths/min |
3.37 |
10.66 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14836 |
381 |
FHH-Chr 14BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
6 |
|
66.49 |
mg/d |
34.22 |
83.82 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52394 |
482 |
FHH-Chr 14BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
64.68 |
% |
7.35 |
19.45 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46350 |
461 |
FHH-Chr 14BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
6 |
|
48.43 |
mmHg |
8.41 |
20.6 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47952 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
66.76 |
% |
7.93 |
19.42 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46107 |
461 |
FHH-Chr 14BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
9 |
|
0.34 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16515 |
381 |
FHH-Chr 14BN/Mcwi |
FAPGG metabolism-surface area product |
FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
7 |
|
43.16 |
ml/min/kg |
6.54 |
17.3 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58213 |
526 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
26.01 |
ml/min |
2.09 |
6.62 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16721 |
381 |
FHH-Chr 14BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
26.66 |
ml/min |
1.52 |
4.81 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16732 |
381 |
FHH-Chr 14BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
4 |
|
66.14 |
mmHg |
6.02 |
12.04 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49919 |
461 |
FHH-Chr 14BN/Mcwi |
serum total bilirubin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77 days-91 days |
8 |
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41909 |
401 |
FHH-Chr 14BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
17.81 |
pg |
0.08 |
0.22 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40184 |
401 |
FHH-Chr 14BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77 days-91 days |
8 |
|
1.75 |
g/dl |
0.05 |
0.14 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
41013 |
401 |
FHH-Chr 14BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
8 |
|
11.41 |
ml/min/kg |
1.35 |
3.83 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59980 |
526 |
FHH-Chr 14BN/Mcwi |
serum chloride level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77 days-91 days |
8 |
|
112.38 |
mmol/l |
0.38 |
1.06 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39158 |
401 |